Transvenous cardioversion in Horses (Equis) | Vetlexicon
equis - Articles

Transvenous cardioversion

ISSN 2398-2977


Introduction

  • Transvenous cardioversion (TVEC) is a complex procedure requiring trained personnel with a high degree of specialist knowledge.

Uses

Advantages

  • Controllable.
  • Minimal morbidity.
  • Efficacious.
  • Predictable.
  • Best for atrial fibrillation or chronic or unknown duration.

Disadvantages

Technical problems

  • Electrode placement can be challenging, needs specialist personnel and equipment.
  • Electrodes can be displaced during anesthetic induction Anesthesia: induction – overview.

Alternative techniques

Time required

Preparation

  • 40-120 min.

Procedure

  • 30-40 min.

Decision taking

Criteria for choosing test

  • Atrial fibrillation Heart: atrial fibrillation of unknown/chronic duration.
  • Owner preference.
  • Horse has previous history of gastric ulceration Stomach: gastric ulceration or recurrent colic Abdomen: pain – adult (contraindicates quinidine sulfate).
  • Quinidine sulfate treatment has failed to convert atrial fibrillation.
  • Recurrence of atrial fibrillation after initial successful medical cardioversion.

Risk assessment

  • As for general anesthesia.

Requirements

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Preparation

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Technique

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Aftercare

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Outcomes

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Further Reading

Publications

Refereed Papers

  • Recent references from PubMed and VetMedResource.
  • van Loon G (2019) Cardiac arrhythmias in horses. Vet Clin North Am Equine Pract 35 (1), 85-102 PubMed.
  • Vernemmem I, De Clercq D, Decloedt A et al (2019) Atrial premature depolarisations five days post electrical cardioversion are related to atrial fibrillation recurrence risk in horses. Equine Vet J 4, PubMed.
  • McGurrin M K, Physick-Sheard P W & Kenney D G (2008) Transvenous electrical cardioversion of equine atrial fibrillation: patient factors and clinical results in 72 treatment episodes. J Vet Intern Med 22 (3), 609-615 PubMed.
  • McGurrin M K, Physick-Sheard P W, Kenney D G, Kerr C & Hanna W J (2005) Transvenous electrical cardioversion of equine atrial fibrillation: technical considerations. J Vet Intern Med 19 (5), 695-702 PubMed.

Organisation(s)

  • University of Edinburgh. Website: www.ed.ac.uk/vet.
  • Professor Lesley Young BVSc DVA DVC DipECEIM PhD MRCVS, Specialist Equine Cardiology Services, UK.